EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasma Preparation Strategies for Extracellular Vesicle‐Based Biomarkers in Metastatic Castration‐Resistant Prostate Cancer

Prima Dewi Sinawang iD, Priyanka Multani, Mehmet O Ozen, Jodie Wong, Demir Akin, Claire Hanson, Matt Larsen, Enos Ampaw, Matthew T Rondina, Neal D Tolley, Liang Wang, Brian T Cunningham und 2 weitere

Journal of Extracellular Biology · 2025-08 · 4 (8)

DOI: 10.1002/jex2.70071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Biology, online erschienen am 31.07.2025. Verfasst von Prima Dewi Sinawang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering Stanford University Stanford California USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) offer a minimally invasive approach for cancer detection and monitoring. However, the lack of standardized methods for clinical biospecimen preparation and EV isolation limits the clinical utility of EV‐based biomarker assessments. A targeted need exists for detailed analysis of plasma EV content. Our study investigates the impact of clinical sample preparation and our ExoTIC device on the quality of plasma‐derived EVs and their RNA/protein cargo in metastatic castration‐resistant prostate cancer (mCRPC) patients. We assessed sample preparation variables: blood anti‐coagulant choice (EDTA or sodium citrate), type of plasma platelet fraction (platelet‐rich or platelet‐poor), and use of protease inhibitors. EVs were isolated via ExoTIC device, followed by EV characterization and biomarker analysis using nanoparticle tracking analysis (NTA), cryogenic electron microscopy, Western blot, and digital PCR (dPCR). We detected mCRPC‐relevant proteins (ARv7 and PSMA) in EVs from all plasma sample types with different sample preparation variables. Additionally, our findings indicate that platelet‐poor plasma (PPP) is optimal for detecting EV‐ and biologically associated mCRPC biomarker miR‐375. In this pilot study ( n = 3), elevated EV miR‐375 levels in PPP samples from mCRPC patients experiencing disease progression during docetaxel treatment were associated with poor therapeutic response to docetaxel chemotherapy, which aligns with our preceding in vitro and in vivo study. Optimal biospecimen preparation for EV analysis could enhance detection accuracy and patient management, highlighting detection of plasma EV‐associated mCRPC‐specific marker proteins (ARv7 and PSMA) and microRNA miR‐375.

Schlagwörter

Stichwörter der Autor:innen

ARv7PSMAextracellular vesiclesfluidic isolation devicemetastatic castration‐resistant prostate cancermiR‐375plasma preparation

Autor:innen und Institutionen

  • Department of Chemical Engineering Stanford University Stanford California USA.
  • Bio-Acoustic MEMS in Medicine (BAMM) Laboratories, Department of Radiology Stanford University Palo Alto California USA.
  • Canary Center at Stanford, Department of Radiology Stanford University Palo Alto California USA.
  • Department of Tumor Microenvironment & Metastasis H. Lee Moffitt Cancer Center Tampa Florida USA.
  • Division of Oncology, Department of Medicine University of Utah Salt Lake City Utah USA.
  • George E. Wahlen Anticoagulation and Thrombosis Service, Division of Hematology and Hematologic Malignancies, Department of Internal Medicine Huntsman Cancer Institute & University of Utah Health Salt Lake City Utah USA.

ORCID-Profile: Prima Dewi Sinawang, Utkan Demirci

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • National Institutes of Health

Zitieren

APA

Sinawang, P. D., Multani, P., Ozen, M. O., Wong, J., Akin, D., Hanson, C., Larsen, M., Ampaw, E., Rondina, M. T., Tolley, N. D., Wang, L., Cunningham, B. T., Kohli, M., & Demirci, U. (2025). Plasma Preparation Strategies for Extracellular Vesicle‐Based Biomarkers in Metastatic Castration‐Resistant Prostate Cancer. Journal of Extracellular Biology, 4(8). https://doi.org/10.1002/jex2.70071

Vancouver

Sinawang PD, Multani P, Ozen MO, Wong J, Akin D, Hanson C, et al. Plasma Preparation Strategies for Extracellular Vesicle‐Based Biomarkers in Metastatic Castration‐Resistant Prostate Cancer. Journal of Extracellular Biology. 2025;4(8). doi:10.1002/jex2.70071

BibTeX
@article{Sinawang2025,
  author = {Sinawang, Prima Dewi and Multani, Priyanka and Ozen, Mehmet O and Wong, Jodie and Akin, Demir and Hanson, Claire and Larsen, Matt and Ampaw, Enos and Rondina, Matthew T and Tolley, Neal D and Wang, Liang and Cunningham, Brian T and Kohli, Manish and Demirci, Utkan},
  title = {Plasma Preparation Strategies for Extracellular Vesicle‐Based Biomarkers in Metastatic Castration‐Resistant Prostate Cancer},
  journal = {Journal of Extracellular Biology},
  year = {2025},
  volume = {4},
  number = {8},
  doi = {10.1002/jex2.70071}
}
Kostenlos starten →